Clinical Trial Update: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and tolerability of YM150 compared with warfarin in atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Warfarin (warfarin)
• YM150

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED